These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

552 related items for PubMed ID: 15975769

  • 1. Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci at a university hospital in Taiwan from 1991 to 2003: resistance trends, antibiotic usage and in vitro activities of newer antimicrobial agents.
    Hsueh PR, Chen WH, Teng LJ, Luh KT.
    Int J Antimicrob Agents; 2005 Jul; 26(1):43-9. PubMed ID: 15975769
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolid.
    Barber KE, Smith JR, Raut A, Rybak MJ.
    J Antimicrob Chemother; 2016 Jan; 71(1):152-5. PubMed ID: 26476277
    [Abstract] [Full Text] [Related]

  • 3. In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan.
    Chen YH, Liu CY, Lu JJ, King CH, Hsueh PR.
    J Antimicrob Chemother; 2009 Dec; 64(6):1226-9. PubMed ID: 19833635
    [Abstract] [Full Text] [Related]

  • 4. Correlation between antimicrobial consumption and resistance among Staphylococcus aureus and enterococci causing healthcare-associated infections at a university hospital in Taiwan from 2000 to 2009.
    Lai CC, Wang CY, Chu CC, Tan CK, Lu CL, Lee YL, Huang YT, Lee PI, Hsueh PR.
    Eur J Clin Microbiol Infect Dis; 2011 Feb; 30(2):265-71. PubMed ID: 20953652
    [Abstract] [Full Text] [Related]

  • 5. [In vitro activity of daptomycin against VRE and MRSA strains].
    Aktaş G, Derbentli S.
    Mikrobiyol Bul; 2014 Jan; 48(1):123-8. PubMed ID: 24506722
    [Abstract] [Full Text] [Related]

  • 6. Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005).
    Sader HS, Watters AA, Fritsche TR, Jones RN.
    BMC Infect Dis; 2007 Apr 18; 7():29. PubMed ID: 17442104
    [Abstract] [Full Text] [Related]

  • 7. Investigation of the prevalence of patients co-colonized or infected with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in China: a hospital-based study.
    Wang Z, Cao B, Liu YM, Gu L, Wang C.
    Chin Med J (Engl); 2009 Jun 05; 122(11):1283-8. PubMed ID: 19567138
    [Abstract] [Full Text] [Related]

  • 8. Correlation between antimicrobial consumption and incidence of health-care-associated infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci at a university hospital in Taiwan from 2000 to 2010.
    Lai CC, Chu CC, Cheng A, Huang YT, Hsueh PR.
    J Microbiol Immunol Infect; 2015 Aug 05; 48(4):431-6. PubMed ID: 24388582
    [Abstract] [Full Text] [Related]

  • 9. Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan.
    Huang YT, Liao CH, Teng LJ, Hsueh PR.
    Clin Microbiol Infect; 2008 Feb 05; 14(2):124-9. PubMed ID: 18076671
    [Abstract] [Full Text] [Related]

  • 10. Antimicrobial activity of mupirocin, daptomycin, linezolid, quinupristin/dalfopristin and tigecycline against vancomycin-resistant enterococci (VRE) from clinical isolates in Korea (1998 and 2005).
    Lee DK, Kim Y, Park KS, Yang JW, Kim K, Ha NJ.
    J Biochem Mol Biol; 2007 Nov 30; 40(6):881-7. PubMed ID: 18047782
    [Abstract] [Full Text] [Related]

  • 11. Treatment options for vancomycin-resistant enterococcal infections.
    Linden PK.
    Drugs; 2002 Nov 30; 62(3):425-41. PubMed ID: 11827558
    [Abstract] [Full Text] [Related]

  • 12. Identification of vancomycin-resistant enterococci clones and inter-hospital spread during an outbreak in Taiwan.
    Lee SC, Wu MS, Shih HJ, Huang SH, Chiou MJ, See LC, Siu LK.
    BMC Infect Dis; 2013 Apr 04; 13():163. PubMed ID: 23556473
    [Abstract] [Full Text] [Related]

  • 13. [Infections caused by multi-resistant Gram-positive bacteria (Staphylococcus aureus and Enterococcus spp.)].
    Cantón R, Ruiz-Garbajosa P.
    Enferm Infecc Microbiol Clin; 2013 Oct 04; 31(8):543-51. PubMed ID: 24041416
    [Abstract] [Full Text] [Related]

  • 14. In vitro activities of Daptomycin, Linezolid, and Quinupristin-Dalfopristin against a challenge panel of Staphylococci and Enterococci, including vancomycin-intermediate staphylococcus aureus and vancomycin-resistant Enterococcus faecium.
    Jevitt LA, Smith AJ, Williams PP, Raney PM, McGowan JE, Tenover FC.
    Microb Drug Resist; 2003 Oct 04; 9(4):389-93. PubMed ID: 15000746
    [Abstract] [Full Text] [Related]

  • 15. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
    Biedenbach DJ, Bell JM, Sader HS, Fritsche TR, Jones RN, Turnidge JD.
    Int J Antimicrob Agents; 2007 Aug 04; 30(2):143-9. PubMed ID: 17531446
    [Abstract] [Full Text] [Related]

  • 16. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: emerging problems and new prospects for management.
    Noskin GA.
    Ann Acad Med Singap; 2001 May 04; 30(3):320-31. PubMed ID: 11455748
    [Abstract] [Full Text] [Related]

  • 17. Emerging issues in the diagnosis and management of infections caused by multi-drug-resistant, gram-positive cocci.
    Napolitano LM.
    Surg Infect (Larchmt); 2005 May 04; 6 Suppl 2():S-5-22. PubMed ID: 23577494
    [Abstract] [Full Text] [Related]

  • 18. [Comparative in vitro activity of daptomycin against gram-positive microorganisms: SENTRY surveillance program, Spain (2002-2006)].
    Loza E, Morosini MI, Pascual A, Tubau F, Alcalá J, Liñares J, Hernández-Bello JR, Baquero F, Perea E, Martín R, Jones RN, Cantón R, SENTRY Surveillance Program, Spain (2002-2006).
    Enferm Infecc Microbiol Clin; 2008 Oct 04; 26(8):489-94. PubMed ID: 19094861
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study.
    Florescu I, Beuran M, Dimov R, Razbadauskas A, Bochan M, Fichev G, Dukart G, Babinchak T, Cooper CA, Ellis-Grosse EJ, Dartois N, Gandjini H, 307 Study Group.
    J Antimicrob Chemother; 2008 Sep 04; 62 Suppl 1():i17-28. PubMed ID: 18684703
    [Abstract] [Full Text] [Related]

  • 20. Increasing prevalence of methicillin-resistant Staphylococcus aureus causing nosocomial infections at a university hospital in Taiwan from 1986 to 2001.
    Hsueh PR, Teng LJ, Chen WH, Pan HJ, Chen ML, Chang SC, Luh KT, Lin FY.
    Antimicrob Agents Chemother; 2004 Apr 04; 48(4):1361-4. PubMed ID: 15047544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.